Nov 04, 2025

Georgia Tech’s Fall 2025 I2P Showcase will feature over 60 student prototypes tackling real-world challenges.

Aug 20, 2025

On August 28, Demo Day 2025 will showcase of 100+ student and faculty-led startups solving real-world problems — no pitches, just interactive tech.

May 30, 2025

CREATE-X celebrates its biggest Startup Launch yet — 318 founders strong — with a public Demo Day on August 28 that promises the unveiling of 100 new startups with bold ideas on tackling real-world problems.

Apr 28, 2025

At the Spring 2025 Idea to Prototype (I2P) Showcase, the winning innovations included Carchive, a prototype that helps car enthusiasts find niche vehicles and their histories; a browser extension by Team Sensible that rates product sustainability and sugg

Mar 28, 2025

SuperStream, founded by John-Wright Stanly, a fourth-year computer science major, won third place in last semester's Idea to Prototype (I2P) Showcase by tackling the challenge of audience engagement through video previews via shared URLs.

Jan 08, 2025

Allez Go and Soul tied for Best Overall projects at the Fall 2024 I2P Showcase, earning spots in the CREATE-X summer startup accelerator and advancing to the InVenture Prize semifinals.

Nov 22, 2024

Georgia Tech's Fall 2024 Idea to Prototype (I2P) Showcase on December 3 will feature over 50 student-built prototypes, including a digital twin for health screenings and an active shooter detection tool, and is open to the entire Georgia Tech community.

Sep 30, 2024

Team Sustain, as a part of CREATE-X Capstone Design, developed a crowdsourced meal system to make home-cooked meals more convenient, showcasing their blend of technical and entrepreneurial skills.

Aug 14, 2024

On Aug. 29, CREATE-X will celebrate its 10th anniversary at Demo Day, showcasing over 100 startups and more than 250 founders.

Aug 02, 2024

Electrosuit, a startup by Aubrey Hall and Sherya Chakraborty, secured third place in the Spring 2024 I2P Showcase, and their product, a garment for at-home electrical stimulation, targets individuals with chronic pain or motor impairments.